Moderna’s website lists all of their patents for the COVID-19 mRNA vaccine technologies, including the patent for PEGylated lipids and other lipid nanoparticle technologies used to deliver mRNA into cells.

Within Moderna’s lipid nanoparticle (LNP) patent for mRNA vaccines, sections 219 and 220 state that;

• mRNA (polynucleotides) may be encapsulated in any hydrogel
• das hydrogel may form a biosynthetic material inside the body that is similar to natural tissue, biocompatible, biodegradable, and/or porous.

Section 220 further states that the hydrogel may be shaped as an inverted opal (inverse opal hydrogel), per the world patent WO2012148684.

Patent WO2012148684 is for the encapsulation of cells and nanoparticles by ichnverse opal HYDROGELS. Why is this important?

Because, one of the purposes of inverse opal hydrogels is for the bioengineering of biosynthetic structures inside living animals by creating genetically hybrid cells inside of the animal’s body. (See highlight below. The patent calls this process cell-based engineering. This is process is also known as biosynthesis.)

Inverse opal hydrogels, are a type of smart (Ai) hydrogel. Smart (Ai) hydrogels are Ai biotechnologies that are merged with quantum dot or Qdot (photonic crystals).

Per the patent WO2012148684, inverse opal hydrogel is used for hybridization of cells in order to bioengineer biosynthetic tissues inside the body of an animal.

The claim that smart (Ai) hydrogels, including opal hydrogels, are used for biosynthetic hybridization is well-established across hundreds of peer-reviewed publications.

Per an article published on December 8, 2021 in Nano Select, smart (Ai) hydrogel is used for tissue bioengineering. Specifically, smart (Ai) hydrogels use the human body and its own elements to bioengineer new structures inside the human body. This process is called biosynthesis.

Bioengineered structures that mimic tissues and organs are called soft actuators. Dies Nano Select article discuses the use of PEGylated lipids for targeted delivery of Ai hydrogels into the cells of specific organs and tissues for purposes of biosynthesis.

Notice that the image of Ai hydrogel encapsulated PEGylated lipid looks like a ‘spike protein’.

Per the scientific publication Nature, soft Ai actuators are highly adaptable and have a variety of applications. They can be configured too look like and mimic the functions of human tissues and organs. However, unlike human tissues and organs, soft Ai actuators are much more agile, versatile, and can more easily be restructured to take on the shape of other structures or organs.

Although soft Ai actuators look like structures of tissues and organs, such as veins and arteries, they are far more than just biosynthetic structures. These bioengineered Ai hybrids can perform more diverse functions beyond those of human cells, tissues, or organs.

Per the book, Self-Assembly and Genetically Engineered Hydrogels, smart Ai hydrogels have an ‘intelligence’ that can; direct their movement, self-heal, and be multi-responsive to the internal environment of the animal they are inside of. This ‘intelligence’ also enables them to respond to external stimuli; including light, sound, temperature, and electromagnetic signals or optics.

Soft Ai actuators (i.e. bioengineered cells, veins, muscles, tumors, etc.) are the ‘progeny’ of smart (Ai) hydrogel.

Smart (Ai) hydrogel adsorbs to a living cell in order to create a hybrid cell. As part of the bioengineered hybrid cell, the smart Ai hydrogel then uses the elements within an animal’s body to further develop itself and other biosynthetic structures. Per the 2021 book Self-Assembly and Genetically Engineered Hydrogels, Ai hydrogels are self-replicating ‘living’ materials.

Essentially, soft Ai actuators and Ai hydrogels are a new bio-hybrid species, because they are part biology and part Ai. These new Ai organisms are alive and can even reproduce (replicate) on their own.

In a BioDesign and Manufacturing article entitled, The Emerging Technology of Biohybrid Micro-Robots: A Review, an example of a PEGlyated lipid nanoparticle hydrogel created ‘blood vessels’ (i.e. soft Ai actuators) is given.

Per the example, PEGylated lipid nanoparticle hydrogels are adsorbed to white blood cells (macrophages) to create a hybrid Ai organism that then produces biosynthetic – endothelial cells, blood cells, and blood vessels (see below image to the left.)

The above image to the right is from Died Suddenly. It’s an image of biosynthetic fibrous structures found within the circulatory system of a dead vaccinated person. (The structures found in the vaccinated deceased are not ‘blood clots’. They are biosynthetic structures bioengineered from Ai hydrogel.)

As you can see, the fibrous structures ‘mimic’ the shape of blood vessels. Ai hydrogels are also biomimetic, meaning that they can copy or imitate the form and shape of living and non-living structures. Ai hydrogels can also imitate biological and chemical functions, such as natural cell death (apoptosis) and cellular regeneration.

Im Died Suddenly, Richard Hirschman also observed small specs of ‘sand like clots’ when draining blood from the corpses. When Mr. Hirschmann placed the dirty blood into a vial, he noticed that the ‘clots’ developed into extremely long thin and stringy fibers.

Hydrogel can be used to grow micro-capillaries (extremely small blood vessels) for patients with certain types of eye disease. (See below image on the left).

On the left hand side is an image of in vitro hydrogel-grown micro-capillaries. On the right hand side are two images from Died Suddenly. One of blood specs on a draining board, and one of the blood specs that were stored in a vial, that then later formed long string-like structures.

While the formation of the fibrous clots in the mRNA vaccinated people is very strange and unusual, it is not without scientific explanation. The lipid nanotechnology used to deliver mRNA into cells includes hydrogel (per Moderna’s patent). The patent specifically mentions the use of inverse opal hydrogel, a type of Ai hydrogel that is specifically used for bioengineering biosynthetic hybrid cells and tissues inside of a living animal from the cells of that animal.

Moderna’s mRNA LNP patent, as well as the disclosed ingredients of the mRNA vaccines, clearly state that PEGylated lipids (i.e. polyethylene glycol) are in the mRNA vaccines. PEGylated lipids are nanoparticle technologies that can be used to deliver Ai hydrogel for purposes of tissue bioengineering inside a living animal.

Per Pfizer’s (and Moderna’s) disclosed ingredients, the mRNA vaccines contain PEGylated lipid nanoparticles (polyethylene glycol).

An individual who claims that ‘it’s a crazy idea’ to think that biosynthetic Ai nanotechnologies could be in the mRNA vaccines is either gaslighting the American people or intentionally ignoring evidence. Experts and even Pfizer agrees that one of the ‘lipids’ is a cationic lipid, meaning it carries an electronic charge. No lipid found in nature can carry an electronic charge. Electronic devices, metals, and Ai organisms can host electronic charges though.